Because the therapeutic effect of Sephin1 on neurodegenerative diseases is to inhibit cell death, and because PP2A subunits A and C are expressed ubiquitously and PP2ABδ is expressed in neurons, it is possible that the mechanism via PP2ABδ is also functioning in the nervous system. The gene discussed is PTPA; the disease is neurodegenerative disease.